by s2desi5_ksqtherapeutics | May 20, 2024
Doug Cole joined Flagship Pioneering in 2001. He focuses on life science. At Flagship, Doug has co-founded Ensemble Therapeutics, Foghorn Therapeutics (NASDAQ: FHTX), Inzen Therapeutics, Moderna (NASDAQ: MRNA), Permeon Biologics, Sigilon Therapeutics, (NASDAQ: SGTX),...
by s2desi5_ksqtherapeutics | May 20, 2024
Alan Crane is a Partner and Entrepreneur at Polaris Partners focusing on building and investing in healthcare companies. He has served as founder and/or has played a significant role as chairman and CEO in building six Polaris companies including: Momenta...
by s2desi5_ksqtherapeutics | May 20, 2024
Mahesh is the President and CEO of Omega Therapeutics (Nasdaq: OMGA), a clinical-stage biotechnology company pioneering a new field of epigenomic programming to use mRNA therapeutics as programmable epigenetic medicines. At Omega, he has led the translation of...
by s2desi5_ksqtherapeutics | May 20, 2024
Ravi Mehrotra joined Flagship Pioneering in 2023. He works with Flagship Growth companies to help maximize value creation opportunities for their bioplatforms. Prior to joining Flagship, Ravi spent 20+ years in biotechnology equity research and investment banking and...
